NEW YORK (GenomeWeb) – Right Patient Right Drug (RPRD) Diagnostics announced today it has agreed to perform preemptive, comprehensive clinical pharmacogenetic testing for St. Jude Children's Research Hospital's PG4KDS program.
To read the full story....
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?
Login Now.